News list
August 9, 2024 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2025[PDF:618KB] Summary of Consolidated Results[PDF:1.2MB] |
June 14, 2024 |
Other |
|
June 5, 2024 |
Investor Relations |
Announcement Regarding Exclusive Sales Cooperation Agreement with Terumo Shanghai[PDF:473KB] |
June 3, 2024 |
Investor Relations |
Notice of the 59th Ordinary General Meeting of Shareholders[PDF:191KB] |
May 21, 2024 |
Investor Relations |
Notice Concerning Formulation of Medium-Term Management Plan.[PDF:3.4MB] |
May 14, 2024 |
Investor Relations |
Financial Results for the FYE March 2024[PDF:513KB] Summary of Consolidated Results[PDF:1.0MB] |
May 14, 2024 |
Investor Relations |
|
May 14, 2024 |
Human Resources |
Notice Regarding Transfer of Representative Director[PDF:421KB] |
May 10, 2024 |
Other |
|
March 22, 2024 |
Other |
|
February 8, 2024 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2024[PDF:320KB] Summary of Consolidated Results[PDF:1.2MB] |
November 7, 2023 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2024[PDF:867KB] Summary of Consolidated Results[PDF:1.1MB] |
November 7, 2023 |
Investor Relations |
|
August 7, 2023 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2024[PDF:357KB] Summary of Consolidated Results[PDF:808KB] |
July 14, 2023 |
Other |
Notice of Changing Subsidiary's Indirectly Owned Subsidiary[PDF:320KB] |
June 5, 2023 |
Investor Relations |
Notice of the 58th Ordinary General Meeting of Shareholders[PDF:206KB] |
May 12, 2023 |
Investor Relations |
Financial Results for the FYE March 2023[PDF:378KB] Summary of Consolidated Results[PDF:849KB] |
May 12, 2023 |
Investor Relations |
|
May 12, 2023 |
Human Resources |
Notice Regarding: Transfer of President and Representative Director and Directors[PDF:290KB] |
February 7, 2023 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2023[PDF:304KB] Summary of Consolidated Results[PDF:1.0MB] |
November 4, 2022 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2023[PDF:341KB] Summary of Consolidated Results[PDF:907KB] |
November 4, 2022 |
Investor Relations |
|
August 5, 2022 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2023[PDF:365KB] Summary of Consolidated Results[PDF:1.1MB] |
June 29, 2022 |
Other |
|
June 3, 2022 |
Investor Relations |
NOTICE OF THE 57TH ORDINARY GENERAL MEETING OF SHAREHOLDERS[PDF:103KB] |
May 12, 2022 |
Investor Relations |
Financial Results for the FYE March 2022[PDF:403KB] Summary of Consolidated Results[PDF:1.1MB] |
April 15, 2022 |
Product |
|
February 8, 2022 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2022[PDF:365KB] Summary of Consolidated Results[PDF:867KB] |
November 5, 2021 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2022[PDF:445KB] Summary of Consolidated Results[PDF:792KB] |
September 17, 2021 |
Other |
Announce the formation of a business alliance with Fresenius Medical Care[PDF:350KB] |
August 6, 2021 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2022[PDF:354KB] Summary of Consolidated Results[PDF:812KB] |
July 30, 2021 |
Other |
Renewal of our website |
May 12, 2021 |
Investor Relations |
Financial Results for the FYE March 2021[PDF:947KB] Summary of Consolidated Results[PDF:1MB] |
February 6, 2021 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2021[PDF:210KB] Summary of Consolidated Results[PDF:745KB] |
November 6, 2020 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2021[PDF:243KB] Summary of Consolidated Results[PDF:714KB] |
August 7, 2020 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2021[PDF:198KB] Summary of Consolidated Results[PDF:640KB] |
June 22, 2020 |
Investor Relations |
Announcement of JMS Group Mid-term Management Plan (April 2020-March 2023)[PDF:366KB] JMS Group Mid-term Management Plan[PDF:728KB] |
May 28, 2020 |
Investor Relations |
Financial Results for the FYE March 2020[PDF:187KB] Summary of Consolidated Results[PDF:796KB] |
February 6, 2020 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2020[PDF:219KB] Summary of Consolidated Results[PDF:699KB] |
November 11, 2019 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2020[PDF:244KB] Summary of Consolidated Results[PDF:775KB] |
August 7, 2019 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2020[PDF:173KB] Summary of Consolidated Results[PDF:767KB] |
May 17, 2019 |
Investor Relations |
Financial Results for the FYE March 2019[PDF:208KB] Summary of Consolidated Results[PDF:922KB] |
February 7, 2019 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2019[PDF:265KB] Summary of Consolidated Results[PDF:746KB] |
November 8, 2018 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2019[PDF:141KB] Summary of Consolidated Results[PDF:777KB] |
August 8, 2018 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2019[PDF:127KB] Summary of Consolidated Results[PDF:582KB] |
May 18, 2018 |
Investor Relations |
Financial Results for the FYE March 2018[PDF:210KB] Summary of Consolidated Results[PDF:672KB] |
May 18, 2018 |
Other |
Notice Regarding: Transfer of Standing Audit & Supervisory Board Member[PDF:32KB] |
March 7, 2018 |
Other |
Notice Regarding Establishment of Joint Venture Companyr[PDF:89KB] |
February 8, 2018 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2018[PDF:275KB] Summary of Consolidated Results[PDF:804KB] |
November 9, 2017 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2018[PDF:250KB] Summary of Consolidated Results[PDF:834KB] |
September 19, 2017 |
Investor Relations |
Announcement of JMS Group Mid-term Management Plan (April 2017-March 2020)[PDF:116KB] |
August 9, 2017 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2018[PDF:216KB] Summary of Consolidated Results[PDF:822KB] |
May 12, 2017 |
Investor Relations |
Financial Results for the FYE March 2017[PDF:297KB] Summary of Consolidated Results[PDF:873KB] |
February 10, 2017 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2017[PDF:237KB] Summary of Consolidated Results[PDF:753KB] |
November 10, 2016 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2017[PDF:133KB] Summary of Consolidated Results[PDF:704KB] |
August 5, 2016 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2017[PDF:243KB] Summary of Consolidated Results[PDF:975KB] |
May 13, 2016 |
Investor Relations |
Financial Results for the FYE March 2016[PDF:87KB] Summary of Consolidated Results[PDF:928KB] |
February 5, 2016 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2016[PDF:50KB] Summary of Consolidated Results[PDF:827KB] |
November 6, 2015 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2016[PDF:83KB] Summary of Consolidated Results[PDF:1.08MB] |
August 7, 2015 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2016[PDF:51KB] Summary of Consolidated Results[PDF:718KB] |
May 8, 2015 |
Investor Relations |
Financial Results for the FYE March 2015[PDF:191KB] Summary of Consolidated Results[PDF:685KB] |
February 5, 2015 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2015[PDF:50KB] Summary of Consolidated Results[PDF:647KB] |
November 6, 2014 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2015[PDF:74KB] Summary of Consolidated Results[PDF:666KB] |
August 7, 2014 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2015[PDF:57KB] Summary of Consolidated Results[PDF:686KB] |
Jun 2, 2014 |
Investor Relations |
|
May 8, 2014 |
Investor Relations |
Financial Results for the FYE March 2014[PDF:99KB] Summary of Consolidated Results[PDF:656KB] |
April 7, 2014 |
Investor Relations |
Business alliance in the field of hemodiafiltration[PDF:83KB] |
February 5, 2014 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2014[PDF:56KB] Summary of Consolidated Results[PDF:644KB] |
December 19, 2013 |
Investor Relations |
Patent and Know-How License Agreement with Huaren Pharmaceutical Co., Ltd.[PDF:89KB] |
November 22, 2013 |
Other |
Our English website has been renewed. |
November 6, 2013 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2014[PDF:62KB] Summary of Consolidated Results[PDF:521KB] |
August 7, 2013 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2014[PDF:54KB] Summary of Consolidated Results[PDF:546KB] |
May 9, 2013 |
Investor Relations |
Financial Results for the FYE March 2013[PDF:84KB] Summary of Consolidated Results[PDF:515KB] |
February 6, 2013 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2013[PDF:70KB] Summary of Consolidated Results[PDF:485KB] |
November 6, 2012 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2013[PDF:63KB] Summary of Consolidated Results[PDF:548KB] |
August 7, 2012 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2013[PDF:48KB] |
June 26, 2012 |
Other |
Notice regarding Executive Change[PDF:39KB] |
May 10, 2012 |
Investor Relations |
Financial Results for the FYE March 2012[PDF:54KB] Summary of Consolidated Results[PDF:907KB] |
February 3, 2012 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2012[PDF:120KB] |
Company
Human Resources
Hiring
Products
Investor Relations
Sustainability
Other